Monopar Therapeutics (MNPR) Leases (2022 - 2025)
Quarterly results put Leases at $254921.0 for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $254921.0 (changed N/A YoY), and the annual figure for FY2025 was $254921.0, changed.
Monopar Therapeutics has reported Leases over the past 3 years, most recently at $254921.0 for Q4 2025.
- Leases reached $254921.0 in Q4 2025 per MNPR's latest filing, up from $106666.0 in the prior quarter.
- Across five years, Leases topped out at $254921.0 in Q4 2025 and bottomed at $9102.0 in Q1 2025.
- Median Leases over the past 3 years was $57461.0 (2022), compared with a mean of $73789.4.
- Peak annual rise in Leases hit 8.04% in 2023, while the deepest fall reached 79.35% in 2023.
- Over 3 years, Leases stood at $61228.0 in 2022, then tumbled by 79.35% to $12646.0 in 2023, then surged by 1915.82% to $254921.0 in 2025.
- Business Quant data shows Leases for MNPR at $254921.0 in Q4 2025, $106666.0 in Q3 2025, and $118170.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 83,048.00 |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | 61,822.50 |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 285.20 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 1.69 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | - |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 189.30 Mn |
| 10 | Monopar Therapeutics | 466.82 Mn | 466.82 Mn | - | 254,921.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 254,921.00 |
| Sep 30, 2025 | 106,666.00 |
| Jun 30, 2025 | 118,170.00 |
| Mar 31, 2025 | 9,102.00 |
| Dec 31, 2023 | 12,646.00 |
| Sep 30, 2023 | 25,088.00 |
| Jun 30, 2023 | 37,330.00 |
| Mar 31, 2023 | 49,376.00 |
| Dec 31, 2022 | 61,228.00 |
| Sep 30, 2022 | 72,889.00 |
| Jun 30, 2022 | 84,363.00 |
| Mar 31, 2022 | 53,694.00 |